Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology
Conditions
- Rectal Adenocarcinoma
- Circulating Tumor DNA
- Minimal Residual Disease
- Neoadjuvant Chemoradiotherapy
Interventions
- DIAGNOSTIC_TEST: MRD detection
Sponsor
WeiWei Xiao
Collaborators